2012 annual financial data
Silence Therapeutics 2012 Operating margin
Direct answer
Operating margin was -3,575.46%.
Operating income was -5,828,000 GBP and net income was -26,284,000 GBP.
Operating cash flow was -4,876,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 163,000 GBP
- Operating income
- -5,828,000 GBP
- Net income
- -26,284,000 GBP
- Operating cash flow
- -4,876,000 GBP